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The huntingtin exon 1 proteins with a polyglutamine repeat in the pathological range (51 or 83
glutamines), but not with a polyglutamine tract in the normal range (20 glutamines), form
aggresome-like perinuclear inclusions in human 293 Tet-Off cells. These structures contain aggre-
gated, ubiquitinated huntingtin exon 1 protein with a characteristic fibrillar morphology. Inclu-
sion bodies with truncated huntingtin protein are formed at centrosomes and are surrounded by
vimentin filaments. Inhibition of proteasome activity resulted in a twofold increase in the amount
of ubiquitinated, SDS-resistant aggregates, indicating that inclusion bodies accumulate when the
capacity of the ubiquitin–proteasome system to degrade aggregation-prone huntingtin protein is
exhausted. Immunofluorescence and electron microscopy with immunogold labeling revealed
that the 20S, 19S, and 11S subunits of the 26S proteasome, the molecular chaperones BiP/GRP78,
Hsp70, and Hsp40, as well as the RNA-binding protein TIA-1, the potential chaperone 14–3-3, and
a-synuclein colocalize with the perinuclear inclusions. In 293 Tet-Off cells, inclusion body forma-
tion also resulted in cell toxicity and dramatic ultrastructural changes such as indentations and
disruption of the nuclear envelope. Concentration of mitochondria around the inclusions and
cytoplasmic vacuolation were also observed. Together these findings support the hypothesis that
the ATP-dependent ubiquitin–proteasome system is a potential target for therapeutic interven-
tions in glutamine repeat disorders.
INTRODUCTION
Huntington’s disease (HD) is an inherited neurodegenera-
tive disorder characterized by personality changes, motor
impairment, and subcortical dementia (Harper, 1991). The
disease is associated with selective neuronal cell death oc-
curring mainly in the cerebral cortex and the striatum (Von-
sattel et al., 1985). The mutation causing HD is a CAG repeat
expansion located within exon 1 of the IT-15 gene encoding
huntingtin, a ;350 kDa protein of unknown function. The
CAG repeat is translated into a polyglutamine (polyQ) se-
quence. In HD patients huntingtin is expressed with 38–182
glutamine residues, whereas in healthy individuals the same
protein is synthesized with only 8–37 glutamine residues
(Rubinsztein et al., 1996; Sathasivam et al., 1997). Thus, HD
manifests itself only when a critical length of ;37 glutamine
residues (pathological threshold) is exceeded.
Perutz et al. (1994) proposed that polyQ chains that exceed
a critical length of 41 residues form anti-parallel b-strands
held together by hydrogen bonds (polar zippers). In vitro
evidence in support of the polar zipper hypothesis has been
presented. Scherzinger et al. (1999) demonstrated that HD
exon 1 proteins with a polyQ tract in the pathological range
($37 glutamines), but not in the normal range (20–32 glu-
tamines), form SDS-insoluble protein aggregates with a
fibrillar morphology. Other laboratories arrived at similar
results (Cooper et al., 1998; Lunkes and Mandel, 1998; Mar-
tindale et al., 1998; Kazantsev et al., 1999). Thus, similar to the
in vivo observations, a polyQ repeat in the pathological
range ($37 glutamines) is critical for the formation of hun-
tingtin protein aggregates in vitro and in cell culture model
systems.
The accumulation of insoluble polyQ-containing protein
aggregates in intranuclear and perinuclear inclusions has
also been detected in brains of HD transgenic mice (Davies
et al., 1997) and HD patients (DiFiglia et al., 1997). These
findings have led to the hypothesis that HD as well as the
related glutamine repeat disorders spinal bulbar muscular
atrophy, dentatorubral pallidoluysian atrophy, and the
spinocerebellar ataxia types 1, 2, 3, 6, and 7 (for review, see
Paulson, 1999) are caused by the accumulation of insoluble
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protein aggregates in neuronal inclusions; however, to this
day it is still unclear whether the formation of inclusion
bodies causes dysfunction and neurodegeneration, or
whether it is merely a defense mechanism to protect neuro-
nal cells from the toxicity of misfolded proteins. In support
of the second possibility, Saudou et al. (1998) and Klement et
al. (1998) presented evidence that the formation of inclusion
bodies with aggregated polyQ-containing protein is non-
toxic or even beneficial for neuronal cells. In strong contrast
to these findings, other investigators have demonstrated that
formation of protein aggregates correlates with disease pro-
gression and the development of neuronal symptoms (Da-
vies et al., 1997; Ona et al., 1999; Yamamoto et al., 2000). Very
recently, using a conditional mouse model of HD,
Yamamoto et al. (2000) showed that expression of mutant
HD exon 1 protein results in inclusion body formation and
progressive motor dysfunction. Blockage of HD exon 1 ex-
pression in symptomatic mice led to disappearance of the
inclusions and the behavioral phenotype. Thus, inclusion
body formation and disease progression appear to be clearly
linked. Furthermore, the development of an HD-like pathol-
ogy is dependent on the continuous expression of a trun-
cated huntingtin protein with a polyQ repeat in the patho-
logical range.
Immunohistochemical and ultrastructural studies have
shown that the aggregated huntingtin protein in neuronal
inclusions of HD transgenic mice and patients is ubiquiti-
nated (Davies et al., 1997; DiFiglia et al., 1997). These findings
suggest that the mutant huntingtin protein has been marked
for degradation by the ubiquitination machinery but that it
is apparently resistant to degradation. Degradation of most
proteins by the proteasome requires the conjugation of mul-
tiple ubiquitin molecules (Bonifacino and Weissman, 1998).
Ubiquitinated proteins are then recognized and hydrolyzed
by the 26S proteasome (Voges et al., 1999). The 26S protea-
some is composed of two major subcomplexes: the 20S pro-
teasome, a barrel-shaped multicatalytic protease, and the
19S (PA700) regulatory complex, which associates with the
20S proteasome. The 19S regulatory complex is required for
the recognition of ubiquitinated proteins. In addition to the
19S complex, a second regulator of the 20S proteasome has
been described. This ring-shaped structure was termed 11S
or PA28 and binds to the 20S proteasome in an orientation
similar to that of 19S. The 11S subcomplex is mainly re-
quired for the degradation of short peptides rather than
large ubiquitinated proteins.
Cummings et al. (1998) showed that ubiquitin-positive
nuclear inclusions in neurons of spinocerebellar ataxia type
1 patients and transgenic mice stain positively for the 20S
proteasome and the molecular chaperone HDJ-2/HSDJ, in-
dicating that subcomplexes of the 26S proteasome as well as
heat shock proteins are redistributed to the sites of ataxin-1
protein aggregation. These results were confirmed in cell
culture, transgenic mouse as well as fly model systems,
using different polyQ-containing proteins (Chai et al., 1999;
Stenoien et al., 1999; Warrick et al., 1999). Together these
findings suggest that the redistribution of the proteasomal
machinery and molecular chaperones to polyQ-containing
protein aggregates is a natural response of cells to remove
misfolded aggregation-prone proteins.
A general relevance of the ubiquitin–proteasome pathway
with regard to the degradation of misfolded proteins has
been proposed. Ward et al. (1995) showed that degradation
of wild-type and mutant cystic fibrosis transmembrane con-
ductance regulator (CFTR) is blocked by specific proteasome
inhibitors resulting in the accumulation of polyubiquiti-
nated forms of CFTR. Immunofluorescence and electron
microscopy also revealed that CFTR molecules aggregate in
distinct perinuclear inclusions (Johnston et al., 1998). The
formation of these structures, termed “aggresomes,” could
be a general response of cells that occurs whenever the
degradative capacity of the proteasome is exceeded. Re-
cently, Wigley et al. (1999) found that under normal condi-
tions the components of the 26S proteasome, as well as
ubiquitin and heat shock proteins, are concentrated at the
centrosome. Interestingly, this structure enlarges in response
to inhibitors of proteasome activity, and additional pools of
chaperones, ubiquitin, and proteasomal subcomplexes are
recruited into the inclusion body. Together these findings
suggest that mammalian cells contain a specific organelle
located at the centrosome that is specialized in the degrada-
tion of misfolded proteins. Disease proteins containing a
polyglutamine tract in the pathological range may resist the
natural degradation in this organelle or disrupt the ubiquit-
in–proteasome system, or both.
In this study we have examined the cellular response to
the formation of polyQ-containing huntingtin aggregates in
293 Tet-Off cells. We found that besides the polyQ repeat-
length, aggregation of huntingtin protein in mammalian
cells is critically dependent on the proteasomal activity.
Inhibition of the activity of the 26S proteasome significantly
enhanced the accumulation of mutant HD exon 1 protein
aggregates. Our data also show that huntingtin aggregation
leads to distinct perinuclear inclusion bodies that are struc-
turally very similar to CFTR aggresomes (Johnston et al.,
1998). Accumulation of insoluble huntingtin aggregates is
toxic for mammalian cells and results in the redistribution of
several cellular factors, such as stress proteins and compo-
nents of the proteasome system to the inclusion bodies.
Taken together, our data support the hypothesis that inclu-
sion bodies with aggregated huntingtin protein accumulate
in mammalian cells mainly because the natural proteasome
system is unable to degrade the expressed mutant hunting-
tin protein.
MATERIALS AND METHODS
Antibodies
The following antibodies were used for immunofluorescence anal-
ysis: rabbit polyclonal CAG53b IgG (diluted 1:250; Davies et al.,
1997), rabbit polyclonal HD1 antibody (diluted 1:2000; Scherzinger
et al., 1997), rabbit polyclonal 14–3-3 antibody (diluted 1:300; this
study), rabbit polyclonal a-synuclein antibody (diluted 1:150; this
study), mouse monoclonal g-tubulin antibody (diluted 1:100; Sigma,
St. Louis, MO), mouse monoclonal vimentin antibody (clone V9,
diluted 1:20; Sigma), mouse monoclonal Flag antibody (diluted
1:2000; Sigma), rabbit polyclonal antibody to 11S regulator subunit
a (PA28a, diluted 1:250; Affiniti Research Products, Exeter, United
Kingdom), rabbit polyclonal antibody to 19S regulator (nonATPase
S10a, diluted 1:80; Affiniti Research Products), rabbit polyclonal
antibody to 20S proteasome core (diluted 1:300; Affiniti Research
Products), mouse IgG2a BiP/GRP78 antibody (diluted 1:500; Trans-
duction Laboratories, Lexington, KY), goat polyclonal antibody to
Hsp40 (C-20, diluted 1:300; Santa Cruz Biotechnology, Santa Cruz,
CA), goat polyclonal antibody to Hsp70 (K-20, diluted 1:300; Santa
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Cruz Biotechnology), mouse monoclonal antibody to TIA-1 (ML-29,
IgG1, 1:200; kindly supplied by Dr. N. Kedersha, Division of Rheu-
matology and Immunology, Brigham and Women’s Hospital, Bos-
ton), rabbit polyclonal antibody to a-mannosidase II (diluted 1:100;
kindly supplied by Kelley Moremen, University of Georgia, and
Marilyn G. Farquhar, University of California, San Diego), second-
ary donkey anti-mouse or anti-rabbit IgG conjugated to either CY3
or FITC (diluted 1:200; Jackson ImmunoResearch, West Grove, PA),
and secondary donkey anti-goat IgG conjugated to Alexa 546 (di-
luted 1:200; Molecular Probes, Eugene, OR).
Preparation of Antibodies
A His6-tagged 14–3-3 fusion protein was generated by inserting the
cDNA coding for amino acids 94–255 of the epsilon isoform of
14–3-3 (Accession No. U54778) into the bacterial pQE-32 expression
vector (Qiagen, Hilden, Germany). Similarly, cDNA coding for
amino acids 1–142 (Accession No. AI739317) of a-synuclein was
cloned into pQE-32. The respective fusion proteins were expressed
in Escherichia coli, affinity purified under denaturing conditions on
Ni-NTA agarose, and injected into rabbits. The resulting immune
sera were used in immunofluorescence studies.
Plasmid Construction
The pTet-CMV-Hyg plasmid used for subcloning of HD exon 1
fragments was generated from the pTetCMV-F° vector (Wu and
Chiang, 1996) as follows. First, a new multiple cloning site with
recognition sites for NdeI, BamHI, SphI, SalI, EcoRV, NotI, and PstI
was ligated 39-terminal to the Flag-tag of the pTetCMV-F° vector.
Second, the hygromycin gene together with the HSV TK promotor
was PCR amplified from pTK-Hyg (Clontech, Palo Alto, CA) and
inserted counterclockwise into the XhoI site of modified pTetCMV-
F°. HD exon 1 fragments with 20, 51, and 83 CAG repeats were
excised from pCAG20, pCAG51, and pCAG83 with BamHI and SalI
(Scherzinger et al., 1997) and subcloned into the BamHI and SalI sites
of pTet-CMV-Hyg yielding pTetCMV-Hyg-CAG20, -CAG51, and
-CAG83, respectively.
Generation of Stable, Inducible Cell Lines
A premade 293 Tet-Off cell line purchased from Clontech was
transfected with 10 mg of pTetCMV-Hyg-CAG20, -CAG51, and
-CAG83 using the calcium phosphate method. The vector
pTetCMV-Hyg was used as a control. Selection of stable cell lines
was initiated 4 d after transfection using 150 mg/ml hygromycin.
Fourteen days after transfection, several colonies were isolated and
cultured in 24-well plates and then transferred into 12-well and
6-well plates and finally into 25 cm2-T flasks. Transgene expression
of induced and noninduced cells was verified by Western blot
analysis and immunofluorescence using antibodies directed against
huntingtin (HD1 and CAG53b) and the Flag-tag.
Culturing of Cell Lines
Stable transfected 293 Tet-Off cells were grown in l-glutamine–free
MEM with Earle’s Salts (Life Technologies, Gaithersburg, MD) and
supplemented with 10% FBS, 2 mM l-glutamine, 100 IU/ml peni-
cillin plus 100 mg/ml streptomycin, 100 mg/ml G418, 150 mg/ml
hygromycin B, and 10 ng/ml doxycycline in poly-l-lysine–coated
cell culture flasks. Expression was induced by thoroughly washing
the cells with PBS and adding fresh medium lacking doxycycline.
The medium was changed on the following day to remove the
doxycycline completely. Expression was induced for different times
as indicated in each individual experiment.
For inhibition of proteasome activity 24 h after induction of
protein expression, cell cultures were adjusted to 10 mM clasto-
lactacystin b-lactone (Affiniti Research Products) and incubated for
an additional 48 h. Control cells were incubated with an equivalent
amount of the solvent DMSO. The cell culture medium and the
proteasome inhibitor were replaced every day.
Preparation of Protein Extracts
Cells were washed, scraped in ice-cold PBS, and pelleted. Cell lysis
was performed on ice for 30 min in 50 mM Tris-HCl (pH 8.8), 100
mM NaCl, 5 mM MgCl2, 0.5% NP-40, and protease inhibitors (2 mM
PMSF, 10 mg/ml leupeptin, 10 mg/ml pepstatin, 1 mg/ml aprotinin,
and 50 mg/ml antipain). Insoluble material was pelleted by centrif-
ugation at 14,000 rpm for 10 min at 4°C. The pellet was resuspended
in 100 ml 20 mM Tris-HCl (pH 8.0)/15 mM MgCl2 containing 0.5
mg/ml DNAseI and incubated for 1 h at 37°C. Protein of the
supernatant and pellet fraction was determined using the Bradford
protein assay (Bio-Rad, Munich, Germany).
For preparation of whole-cell extracts, cells were washed, scraped
in ice-cold PBS, and pelleted. Lysis was performed on ice for 30 min
in a buffer containing 50 mM Tris-HCl (pH 8.8), 100 mM NaCl, 5
mM MgCl2, 0.5% NP-40, protease inhibitors (as described above),
and 250 U/ml benzonase. Protein concentration was determined
using the Bradford protein assay.
Western Blot Analysis and Filter Retardation Assay
Proteins were denatured, reduced, separated by SDS-PAGE (12.5%),
and transferred to nitrocellulose according to standard procedures.
Membranes were blocked with 3% nonfat dry milk in PBS contain-
ing 0.05% Triton X-100 and incubated with the anti-huntingtin
antibody HD1 (diluted 1:1000) or an anti-ubiquitin antibody (dilut-
ed 1:500), respectively. The secondary antibody was a peroxidase-
conjugated anti-rabbit antibody. Immunoreactive protein was de-
tected by using enhanced chemoluminescence (ECL, Boehringer
Mannheim, Mannheim, Germany). For the filter retardation assay
(Scherzinger et al., 1997; Wanker et al., 1999), protein extracts were
heated at 98°C for 3 min in 2% SDS and 50 mM DTT and filtered
through a 0.2-mm cellulose acetate membrane (Schleicher & Schuell,
Dassel, Germany) using a BRL dot-blot filtration unit. Filters were
processed for immunodetection as described above, using an alka-
line–phosphatase-conjugated anti-rabbit secondary antibody and
the fluorescent substrate AttoPhos (JBL Scientific, San Luis Obispo,
CA). The relative amount of captured aggregate was evaluated with
the Fuji-Imager LAS 2000 (Tokyo, Japan).
Immunofluorescence and Electron Microscopy
Induced cells were grown in leighton tubes (Costar, Cambridge,
MA) for the indicated times. After cells were washed with PBS, they
were fixed in 4% paraformaldehyde for 15 min at room tempera-
ture, permeabilized with 0.1% Triton X-100 for 15 min, and blocked
with 3% BSA for 30 min. Cells were then incubated for 1 h at room
temperature with the appropriate primary antibodies diluted in
PBS, washed three times for 10 min with 0.1% Triton X-100, and
incubated for 1 h at room temperature with the secondary antibod-
ies diluted in PBS containing 3% goat serum. After the leightons
were washed in 0.1% Triton X-100 and in PBS, cell nuclei were
counterstained with Hoechst (Sigma). Samples were viewed with
the fluorescence microscope Axioplan-2 (Zeiss, Thornwood, NY).
For electron microscopic analysis, cells were grown on poly-l-
lysine–coated Thermanox coverslips (13 mm diameter; Nunc, Na-
perville, IL), and transgene expression of the HD exon1 proteins
was induced for 3 d. For embedding in LR Gold Resin (London
Resin Company, Berkshire, United Kingdom), coverslips with cells
were washed in PBS and fixed for 1 h in a mixture of 1% formal-
dehyde and 0.2% glutaraldehyde. After dehydration in an ethanol
series, cells were infiltrated with LR Gold as described by suppliers.
Polymerization was performed under visible light for 3 d in the
presence of benzil. For embedding in Spurr’s resin, cells were fixed
in 2% glutaraldehyde, treated for 1 h with 2% osmium tetroxide,
and dehydrated in an acetone series. After gradual transfer from
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100% acetone to pure resin, polymerization was performed at 60°C
overnight. For polymerization, coverslips were placed upside down
on top of resin-filled gelatin capsules in both cases.
For immunolabeling, 60-nm sections on nickel grids were incu-
bated for 10 min in buffer A (20 mM Tris-HCl, pH 7.5, 150 mM
NaCl), followed by another 10 min of incubation in buffer B (buffer
A containing 6 mg/ml Aurion BSA-c, Wageningen, The Nether-
lands). Antibodies against HD1 (1:400), ubiquitin (1:30), or 14–3-3
(1:400) were added to buffer B and incubated for 2 h at room
temperature. After four 10 min washes in buffer B, secondary anti-
body conjugated with 10 nm gold (1:100; British Bio Cell, Cardiff,
United Kingdom) was applied in buffer B for 2 h at room temper-
ature. After extensive washing in buffer A, sections were post-
stained for 1 min with 0.5% uranyl acetate and for 45 s with lead
citrate and then viewed in a Philips CM100 EM (Philips Electron
Optics, Eindhoven, The Netherlands).
Cell Viability Assay
Cell viability was measured by cleavage of the yellow tetrazolium
salt XTT to form an orange formazan dye by metabolic active cells
(Roche Molecular Biochemicals, Mannheim, Germany). One day
before measuring XTT cleavage, cells were plated in 96-well plates
at a density of ;7000 cells per well. XTT was added 4 d after
induction of HD exon 1 expression following the manufacturer’s
protocol. After 5 h of incubation at 37°C, the optical density was
measured at 450 nm with a reference wave length set at 690 nm. For
each cell line examined, nine independent values were measured
and evaluated statistically.
RESULTS
Expression of Mutant HD Exon 1 Proteins in 293
Tet-Off Cells Results in Aggregate Formation
The tetracycline (tet)-regulated system (Gossen and Bujard,
1992) has been used for the expression of Flag-tagged HD
exon 1 proteins with 20 (HDQ20), 51 (HDQ51), and 83
(HDQ83) glutamines in 293 Tet-Off cell lines (Figure 1A).
Regulation of this system is achieved through a tet-regulated
transactivator, a fusion protein consisting of the tet-repres-
sor, and a VP16 activation domain. This hybrid protein
binds specifically to a tetracycline-responsive DNA element
TRE and promotes transcription from the adjacent CMV
promoter. Tetracycline and its analogues such as doxycy-
cline can bind to the transactivator and thereby prevent the
hybrid protein from binding to the TRE element. Thus, if
doxycycline is present in the cell culture medium, transcrip-
tion of recombinant HD exon 1 constructs in 293 Tet-Off cells
is inhibited, whereas in its absence HD exon 1 expression is
induced.
293 Tet-Off cell lines were cultivated for 3 d in either the
absence or presence of doxycycline. Whole-cell extracts were
prepared, and after centrifugation the soluble (supernatant)
and insoluble (pellet) fractions were analyzed by SDS-PAGE
and Western blotting (Figure 1B). In the supernatant frac-
tions from cells that have been grown in the absence of
doxycycline, prominent bands migrating at 20, 35, and 45
kDa corresponding to the proteins HDQ20, HDQ51 and
HDQ83, respectively, were detected by the anti-huntingtin
antibody HD1 (lanes 4, 6, and 8). These bands were barely
detected in the corresponding fractions of uninduced cells
(lanes 3, 5, and 7). In supernatant fractions prepared from
control cells lacking the HD exon 1 construct, recombinant
HD exon 1 protein was not observed by immunoblotting
using the HD1 antibody (lanes 1 and 2) in either the absence
or presence of doxycycline. Insoluble protein aggregates that
did not enter the stacking gel were detected in the pellet
fractions prepared from cells expressing the proteins
HDQ51 and HDQ83 (lanes 6 and 8), but not in the corre-
sponding fraction of HDQ20-expressing cells (lane 4). These
results confirm earlier results (Scherzinger et al., 1999) show-
ing that a polyQ repeat in the pathological range is critical
for the formation of aggregates in 293 Tet-Off cells. Gel-
excluded HD exon 1 aggregates were also detected by an
anti-Flag antibody and an antibody specifically directed
against ubiquitin, indicating that they are ubiquitinated (Fig-
ure 1B).
The time course of HD exon 1 aggregation in the stable
transfected 293 Tet-Off cell lines is shown in Figure 1C.
Expression of HD exon 1 proteins was induced by removal
of doxycycline from the culture medium. After incubation
for various times (1–6 d), cell extracts were prepared and
analyzed for the presence of insoluble HD exon 1 aggregates
by a filter retardation assay. SDS-resistant HDQ83 aggre-
gates were detected after a lag phase of 2–3 d, whereas
under the same conditions the HDQ51 protein required 4–5
d to develop detectable high molecular weight aggregates.
In induced cells expressing HDQ20, no SDS-insoluble pro-
tein aggregates were detected, even after an incubation of
6 d. These findings confirm our previous results using COS
cells that HD exon 1 aggregation is polyglutamine-length
dependent, and that a polyglutamine tract in the patholog-
ical range ($37 glutamines) is required for the formation of
high molecular weight protein aggregates in vitro (Scherz-
inger et al., 1999).
Aggregate formation in 293 Tet-Off cells was also assessed
by indirect immunofluorescence microscopy (Figure 2). Af-
ter induction of HD exon 1 expression for 3 d by removal of
doxycycline from the culture medium, cells were immuno-
labeled with the anti-Flag antibody; nuclei were counter-
stained with Hoechst. Homogenous cytoplasmic staining
was observed in cells expressing HDQ20 protein (Figure 2a).
In sharp contrast, distinct cytoplasmic and nuclear inclu-
sions containing aggregated huntingtin protein were de-
tected in cells expressing the proteins HDQ51 or HDQ83
(Figure 2, b and c). In the vast majority (.80%) of cells, the
HD exon 1 protein aggregates accumulated in the perinu-
clear region and appeared as spherical structures with a
diameter of 1–3 mm. Interestingly, inclusion formation re-
sulted in a change of the shape of the adjacent nuclei, sug-
gesting that the accumulation of insoluble HD exon 1 pro-
tein aggregates demolishes the structure of the nuclei. Both
nuclear and cytoplasmic inclusions reacted with the anti-
Flag monoclonal antibody and also with the anti-ubiquitin
antibody (our unpublished results).
Cytoplasmic HD Exon 1 Protein Aggregates
Colocalize with the Centrosome/Microtubule-
organizing Center and Lead to Intracellular
Redistribution of Vimentin
Johnston et al. (1998) showed that misfolded, ubiquitinated
CFTR protein accumulates in characteristic perinuclear in-
clusions, which they termed aggresomes. Aggresomes form
specifically at the centrosome and are surrounded by the
intermediate filament vimentin. To examine whether the
perinuclear HD exon 1 protein aggregates are related in
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structure to CFTR aggresomes, colocalization studies were
performed using immunofluorescence microscopy. Compar-
ison of the fluorescence of HDQ83 protein aggregates with
the immunostaining of g-tubulin, a known marker for the
centrosome (Dictenberg et al., 1998), revealed that both struc-
tures colocalize at least partially (Figure 2d). On the other
hand, the fluorescence of the HD exon 1 protein aggregates
did not overlap with the immunostaining of a-mannosidase
II, a marker for the Golgi apparatus (Figure 2e), indicating
that the Golgi apparatus, which is also located in the perinu-
clear region (Velasco et al., 1993), is distinct from the HDQ83
protein aggregates. Accumulation of mutant HDQ83 protein
in 293 Tet-Off cells also appeared to cause the reorganization
of the intermediate filament vimentin. As shown in Figure
2f, vimentin filaments form a ring-like structure around the
HDQ83 protein aggregates. In comparison, a branching cy-
toskeletal network that extends to the cell periphery was
detected in control cells. Together, these findings indicate
that the perinuclear inclusion bodies containing aggregated
HDQ51 or HDQ83 protein are structurally similar to the
aggresomes that have been described previously for CFTR
(Johnston et al., 1998).
Colocalization of Proteasomal Components with
HD Exon 1 Aggregates and Enhancement of
Aggregate Formation in Response to Proteasome
Inhibition
The proteasome has been generally implicated in the degra-
dation of misfolded proteins (Kopito, 1997). To determine
whether the key components of the 26S proteasome are
redistributed to perinuclear inclusion bodies, induced 293
Tet-Off cells expressing HDQ83 protein were analyzed by
immunofluorescence microscopy. Figure 3 shows that the
proteasomal subcomplexes 20S, 19S, and 11S colocalize with
the insoluble HDQ83 protein aggregates, suggesting that the
26S proteasome is directly involved in the degradation of
aggregated HD exon 1 protein. To further test this hypoth-
esis, cells expressing the HDQ51 protein were treated with
the proteasome inhibitor clasto-lactacystin b-lactone, and the
formation of SDS-insoluble HD exon 1 protein aggregates
was analyzed using the filter retardation assay. The amount
of HDQ51 aggregates in clasto-lactacystin b-lactone–treated
cells was found to be roughly twofold higher than that of
untreated cells or cells that had been treated with the solvent
DMSO, indicating that proteasomal activity of the cell is
critical for the accumulation of perinuclear polyQ-contain-
ted onto nitrocellulose membranes, and probed with the anti-hun-
tingtin antibody HD1 (top and middle panel) or with anti-ubiquitin
antibody (bottom panel). Lanes 1 and 2: protein fractions prepared
from induced and uninduced control cells lacking the HD exon 1
construct; lanes 3, 5, and 7: protein fractions prepared from unin-
duced cells; lanes 4, 6, and 8: protein fractions prepared from
induced cells expressing the proteins HDQ20, HDQ51, and HDQ83,
respectively. Arrows mark the origin of electrophoresis. (C) Time
course of HD exon 1 aggregation in 293 Tet-Off cells. Expression of
the recombinant proteins was induced by removal of doxycycline
from the culture medium. Protein extracts were prepared at the
indicated times after induction and analyzed by a filter retardation
assay. Captured HD exon 1 protein aggregates were detected with
the HD1 antibody.
Figure 1. Cell model design and analysis of HD exon 1 protein
aggregation in 293 Tet-Off cells. (A) Activation of the transactivator
tTA, a fusion protein consisting of the tet-repressor and the VP16
activation domain, by removal of doxycycline (Dox) from the cul-
ture medium results in the binding of tTA to the tet-responsive
element TRE and transcription of Flag-tagged HD exon 1 fragments
with 20, 51, and 83 CAG repeats in 293 Tet-Off cells. (B) Immunoblot
analysis of soluble (supernatant) and insoluble (pellet) protein frac-
tions prepared from induced and uninduced 293 Tet-Off cells. For
induction of HD exon 1 expression, cells were grown for 3 d in the
absence of doxycycline. Proteins were resolved by SDS-PAGE, blot-
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ing protein aggregates (Figure 4A). Essentially the same
result was obtained when the number of cells with perinu-
clear inclusion bodies was determined by indirect immuno-
fluorescence microscopy (Figure 4B).
The Endoplasmic Reticulum (ER) Resident
Chaperone BiP/GRP78 Is Recruited into Perinuclear
Inclusion Bodies
Chaperones are expected to play a protective role during
polyQ aggregation in mammalian cells (Cummings et al.,
1998; Warrick et al., 1999). Recently, we have shown in vitro
that both Hsp40 and Hsp70 are effective in preventing the
formation of SDS-insoluble polyQ-containing fibrillar struc-
tures (Muchowski et al., 2000). Here, we used indirect im-
munofluorescence to examine whether distinct classes of
chaperones associate with insoluble HDQ83 aggregates in
293 Tet-Off cells. First, the colocalization of GRP78, an ER
resident chaperone, with the perinuclear inclusion bodies
was analyzed. In the ER, GRP78 associates with misfolded or
incompletely assembled proteins, which are destined for
proteolytic degradation (Voges et al., 1999). An association of
this chaperone with cytoplasmic polyglutamine-containing
protein aggregates has not been described previously. Un-
expectedly we found that GRP78 colocalizes with the core of
the HDQ83 inclusion bodies (Figure 5, a–c). In a typical
experiment, 40–50% of the inclusion bodies examined con-
tained GRP78. Colocalization between GRP78 and inclusion
bodies was detected at an early stage of the HDQ83 aggre-
gation process. Thus, 2 d after induction of HDQ83 expres-
sion, when the first perinuclear inclusion bodies could just
be detected by immunofluorescence microscopy, colocaliza-
tion between GRP78 and HDQ83 inclusion bodies was ap-
parent. This suggests that recruitment of GRP78 into HD
exon 1 aggregates belongs to the earliest responses of cells in
their fight to prevent the accumulation of misfolded protein.
In comparison, at this stage colocalization between HDQ83
aggregates and the cytoplasmic chaperones Hsp70 and
Hsp40 was barely detectable. A significant enrichment of
Hsp70 and Hsp40 at the inclusion bodies was not detected
before 5–7 d after induction of HDQ83 expression, indicat-
ing that the recruitment of these cytoplasmic chaperones is a
late event in the process of inclusion formation (Figure 5,
d–i).
Colocalization of TIA-1, 14–3-3e, and a-Synuclein
with Perinuclear Inclusions
To assess whether in addition to chaperones and compo-
nents of the ubiquitin–proteasome system other cellular fac-
tors are recruited into inclusion bodies, a number of different
antibodies were tested by indirect fluorescence microscopy.
Two to 3 d after induction of HDQ83 expression, the RNA
binding protein TIA-1 (Kedersha et al., 1999), the potential
Figure 2. HD exon 1 aggregates form at the centrosome and result in the redistribution of the intermediate filament vimentin. (a–c)
Expression of the proteins HDQ20, HDQ51, and HDQ83 was induced for 3 d by removal of doxycycline from the culture medium. Cells were
processed for immunofluorescence using the anti-Flag antibody followed by the CY3-coupled secondary antibody. Nuclei were counter-
stained with Hoechst. Cells expressing the HDQ20 protein showed homogenous cytoplasmic staining (a), whereas in cells expressing the
proteins HDQ51 (b) or HDQ83 (c), distinct inclusion bodies were observed. Immunofluorescence double labeling of cells reveals that
FITC-labeled HDQ83 aggregates (green) partially colocalize with CY3-labeled g-tubulin (red), a centrosomal marker (d), but not with
CY3-labeled a-mannosidase II, a known Golgi marker (e). Induction of HDQ83 expression for 3 d also results in a redistribution of
CY3-labeled vimentin to the perinuclear inclusion bodies (f). Note the ring-like appearance of vimentin fluorescence in cells containing
HDQ83 protein aggregates. In comparison, in control cells lacking HDQ83 protein, the vimentin filaments extend to the cell periphery. Bar,
10 mm.
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chaperone 14–3-3e (Shaw, 2000), and a-synuclein (Souza et
al., 2000) were found to be present in perinuclear inclusion
bodies (Figure 6), suggesting that recruitment of these pro-
teins into HD exon 1 aggregates belongs to an early response
of a cell to remove the misfolded protein. Five to 7 d after
induction of HDQ83 expression, colocalization of amyloid-b
(Masters et al., 1985) and presenilin 1 (Sherrington et al.,
1995) with inclusion bodies could also be detected, indicat-
ing that the accumulation of amyloid-b and presenilin-1 are
relatively late events in the process of inclusion body for-
mation (our unpublished results).
Ultrastructure of Perinuclear Inclusions
Cells of transgenic 293 Tet-Off lines were incubated for 2–5
d in the absence of doxycycline and then analyzed by trans-
mission electron microscopy. Although cells expressing
HDQ20 appeared normal, in cells expressing the mutant HD
exon 1 proteins, characteristic morphological changes were
observed. At the ultrastructural level, cells expressing
HDQ83 contained relatively large membrane-free, spherical
structures (diameter ;1–5 mm) composed of electron-dense
filamentous material (Figure 7, a and b). At higher magnifi-
cation it was possible to determine that the fibrous region
consists of individual filaments with a diameter of ;10 nm
(Figure 7, c and d). These filaments are reminiscent of HD
exon 1 fibrils that have been produced previously in vitro
(Scherzinger et al., 1997) as well as in HD transgenic mouse
models (Davies et al., 1997). The identity of the HDQ83
filaments was confirmed by immunoelectron microscopy
using the anti-huntingtin antibody HD1 and a gold colloid
secondary antibody. At a higher magnification, decoration
of the 10 nm fibrils with 10 nm gold particles is evident
(Figure 7d).
To further characterize the inclusion bodies, cells express-
ing HDQ83 were immunogold labeled with antibodies di-
rected against ubiquitin and 14–3-3e. As shown in Figure 7,
h and i, the inclusions were selectively labeled with each
antibody, confirming the presence of ubiquitin and 14–3-3e
in the core region of the inclusion body. These findings
support the hypothesis that aggregated HDQ83 protein is
ubiquitinated and that certain cellular proteins are recruited
into these structures. Frequently, the nuclei from cells con-
taining inclusion bodies were seen to contain large indenta-
tions in their envelope (Figure 7, a and e). Similar changes of
nuclei have also been described for neuronal cells of HD
transgenic mice and patients (Roizin et al., 1979; Davies et al.,
1997). At higher magnification, a clear disruption of the
nuclear membrane was obvious (Figure 7f), suggesting that
inclusion body formation not only alters the shape of nuclei
Figure 3. Colocalization of
HDQ83 protein aggregates with
the proteasomal subcomplexes
20S, 11S, and 19S. After induction
of HDQ83 expression for 3 d, cells
were double immunolabeled with
antibodies directed against 20S/
HDQ83 (a–c), 11S/HDQ83 (d–f),
and 19S/HDQ83 (g–i). HDQ83
protein aggregates were immuno-
labeled with anti-Flag antibody
coupled to a FITC-conjugated an-
tibody (green); proteasomal sub-
complexes were labeled with anti-
20S, anti-11S, and anti-19S
antibodies coupled to CY3 anti-
body (red). Cells were counter-
stained with Hoechst, allowing
the detection of nuclei. Bar, 5 mm.
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but also disrupts, at least partially, the nuclear envelope.
Frequently, disintegration of organelles such as mitochon-
dria, vacuoles, and vesicular structures was observed in cells
containing large inclusion bodies, and mitochondria, espe-
cially, appeared to be trapped at the periphery of the fila-
mentous inclusion bodies (Figure 7g). In the periphery, but
not in the interior of inclusions, bundles of the intermediate
filament vimentin were also detected, confirming the results
obtained by immunofluorescence microscopy (Figure 2f).
None of these alterations were found in cells expressing
HDQ20 protein (our unpublished results).
Expression of Mutant HD Exon 1 Protein Is Toxic
for 293 Tet-Off Cells
Expression of HDQ83, HDQ51, and HDQ20 in stable trans-
fected cell lines was induced for 4 d, and cell viability was
determined using the XTT assay. As shown in Figure 8, the
viability of 293 Tet-Off cells decreased in a glutamine repeat
length–dependent manner. For example, viability of cells
expressing the HDQ83 protein was reduced approximately
twofold compared with cells expressing the HDQ20 protein.
At the time when cell viability was examined, ;30–50% of
all cells expressing the proteins HDQ51 or HDQ83 contained
large perinuclear inclusions; no such structures were ob-
served in cells expressing the HDQ20 protein. Thus, cells
containing inclusion bodies appear to be significantly less
viable than cells lacking aggregated protein. These results
suggest that the process of aggregate formation causes tox-
icity in the 293 Tet-Off cell lines.
DISCUSSION
In this study we have generated inducible cell lines for the
detailed analysis of huntingtin protein aggregation in mam-
malian cells. Our data demonstrate that overexpression of
HD exon 1 protein fragments with a polyQ repeat in the
pathological range (51 and 83 glutamines), but not with a
polyQ repeat in the normal range (20 glutamines), results in
the formation of massive cytoplasmic inclusions that are
toxic for 293 Tet-Off cells. These inclusions contain aggre-
gated, ubiquitinated HD exon 1 protein with a fibrillar mor-
phology and are structurally very similar to the neuronal
inclusions that have been detected previously in brains of
HD patients and transgenic animals (Davies et al., 1997;
DiFiglia et al., 1997). Recently, Wigley et al. (1999) presented
evidence that the centrosome or a closely associated struc-
ture may play a functional role in the degradation of mis-
folded proteins in mammalian cells. Using immunofluores-
cence microscopy, they identified a specific structure in the
centrosomal region in which components of the 26S protea-
some, as well as ubiquitin and heat shock proteins, are
concentrated under basal conditions. Inhibition of the pro-
teasome activity as well as overexpression of mutant CFTR
(Johnston et al., 1998) resulted in an enlargement of this
centrosome-associated structure and the formation of large
perinuclear inclusion bodies with undegraded protein.
These results suggest that mammalian cells contain a spe-
cific organelle that is specialized in the degradation of mis-
folded aggregation-prone proteins and peptides. Our results
obtained with mutant and wild-type HD exon 1 proteins are
in agreement with this prediction, and we propose to term
this structure “degrasome.” We found that inclusion bodies
with aggregated huntingtin protein accumulate in the pe-
rinuclear region at or near the centrosome. Furthermore, the
amount of ubiquitinated huntingtin protein aggregates in
inclusions was found to increase twofold when the activity
of the proteasome was inhibited by lactacystin. These results
indicate that the amount of huntingtin protein that accumu-
lates in inclusion bodies is highly dependent on the activity
of the proteasome.
A model for the accumulation of polyQ-containing pro-
tein aggregates in 293 Tet-Off cells is outlined in Figure 9.
We propose that under normal conditions, misfolded cellu-
lar proteins as well as wild-type and mutant HD exon 1
Figure 4. The amount of HDQ51 aggregates in 293 Tet-Off cells
increases in response to proteasome inhibition. (A) After induction
of HDQ51 expression for 1 d, cells were treated for 48 h with
lactacystin. Protein extracts were prepared as described in MATE-
RIALS AND METHODS and analyzed by the filter retardation
assay. Captured aggregates were detected by incubation with HD1
antibody, followed by incubation with alkaline phosphatase-conju-
gated anti-rabbit secondary antibody and the fluorescent substrate
AttoPhos. The relative amount of aggregates for each sample was
quantified on a Fuji-Imager (LAS2000). The dot with the highest
signal intensity was arbitrarily set as 100. The data shown are
representative of three independent experiments. (B) After induc-
tion of HDQ51 expression for 8 h, cells were treated for 24 h with
lactacystin (10 mM). Formation of inclusion bodies was followed by
indirect immunofluorescence microscopy using the CAG53b anti-
body. A total of ;6000 lactacystin-treated and untreated cells were
examined in each experiment.
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protein fragments are transported to the degrasome for pro-
teolytic digestion; however, although the HD exon 1 protein
with 20 glutamines can be successfully degraded by the
ubiquitin–proteasome system, which is concentrated in the
degrasome, the HD exon 1 protein with a long polyQ repeat
(51 and 83 glutamines) polymerizes into insoluble fibrils that
resist proteolytic degradation. Once the first nuclei and
fibrillar structures have formed, the cell responds to the
accumulation of mutant protein with the recruitment of
additional proteins such as ubiquitin, heat shock proteins,
and proteasomal subcomplexes that coassemble with aggre-
gated huntingtin protein. Thus, we have shown that the
resulting inclusion bodies, termed aggresomes by Johnston
et al. (1998), contain a number of different proteins such as
GRP78, 14–3-3, a-synuclein, 19S, 20S, and 11S in addition to
the aggregated huntingtin protein (Figures 3, 5, and 6). We
suggest that the accumulating huntingtin fibrils inhibit the
proteasomal activity and thereby obstruct the cellular stress
response pathway for misfolded protein. Thus, after a cer-
tain time, in addition to the mutant huntingtin fragments,
other misfolded cellular proteins, which are normally di-
gested in the degrasome, are also accumulating. Immuno-
fluorescence microscopy revealed that 5–7 d after induction
of HDQ83 expression, proteins and peptides such as amy-
loid-b or presenilin-1 also accumulate in the perinuclear
inclusion bodies (our unpublished results). The redistribu-
tion of the cytoplasmic heat shock proteins Hsp40 and
Hsp70 and the intermediate filament vimentin is another
response to the accumulation of insoluble huntingtin fibrils.
We speculate that after a certain time the cell recognizes that
it will lose the battle against the accumulating protein ag-
gregates and begins to isolate them from their natural envi-
ronment. The encapsulation of aggregated huntingtin pro-
tein with the intermediate filament vimentin may be one
such strategy.
Our data, however, indicate that this strategy is not very
successful. Ultrastructural studies showed that the process
of aggregate formation dramatically alters the cellular envi-
ronment (Figure 7). Inclusion body formation not only
changes the shape of the adjacent nuclei, it also destroys the
nuclear envelope. Furthermore, mitochondria are dislocated
to the area surrounding the inclusion bodies; it seems as if
they are caught by the fibrillar structures. The reason for the
concentration of mitochondria in the vicinity of the inclusion
bodies is not immediately obvious. It is well known that
mitochondria play a crucial role in the activation of specific
apoptotic pathways: under certain conditions they are con-
centrated in the perinuclear region (Desagher and Martinou,
2000). Furthermore, there is accumulating evidence that mi-
tochondrial dysfunction is linked to the pathogenesis of
neurodegenerative disorders such as HD (Beal, 2000). We
suggest that mitochondria concentrate at inclusion bodies
Figure 5. Chaperones are re-
cruited into HD exon 1 aggre-
gates. HDQ83 expression was in-
duced by removal of doxycycline
from the culture medium. Three
days after induction of HDQ83,
expression cells were double im-
munolabeled with antibodies di-
rected against BiP and HDQ83 (a–
c). Double immunolabeling of
cells with antibodies directed
against Hsp70/HDQ83 (d–f) and
Hsp40/HDQ83 (g–i) was per-
formed on day 6 after induction
of HDQ83 expression. HDQ83
protein aggregates were immuno-
labeled with anti-CAG53b cou-
pled to FITC-conjugated second-
ary antibody (green); chaperones
were labeled with antibodies di-
rected against BiP, Hsp70, and
Hsp40 coupled to a CY3-conju-
gated secondary antibody (red).
Nuclei were counterstained with
Hoechst. Colocalization of
HDQ83 aggregates with BiP,
Hsp70, and Hsp40 is shown in c,
f, and i, respectively. Bar, 5 mm.
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because the ubiquitin–proteasome system, which tries to
degrade the amyloid-like huntingtin protein, requires addi-
tional ATP; however, the energetics of cells containing in-
clusion bodies with aggregated huntingtin protein has to be
examined in more detail to understand this phenomenon.
Our data suggest that the redistribution of the proteins
GRP78, 14–3-3, a-synuclein, and TIA-1 to inclusion bodies
belongs to an early stress response of cells in their struggle
for survival. There is experimental evidence to indicate that
GRP78, 14–3-3, and a-synuclein function as chaperones
(Bonifacino and Weissman, 1998; Shaw, 2000; Souza et al.,
2000), whereas TIA-1 has been characterized as a stress-
induced RNA-binding protein (Kedersha et al., 1999). Chap-
erones are known to bind to misfolded aggregation-prone
polypeptides, thereby diminishing the likelihood of aggre-
gate formation (Hartl, 1996). Thus, we suggest that chaper-
ones accumulate at inclusion bodies either to refold mis-
folded protein or to totally unfold polypeptide chains for
their efficient degradation. In particular, the recruitment of
the ER-resident chaperone GRP78 into the cytoplasmic in-
clusion bodies was unexpected. GRP78 is known to associate
with misfolded aggregation-prone proteins in the ER. Ret-
rograde transport of this protein from the ER into the cyto-
plasm, however, has not been described. It is possible that
GRP78 is transported into the cytoplasm via the Sec61 pro-
tein complex (Plemper et al., 1997) or, alternatively, is
present in the cytoplasm because the huntingtin fibrils have
disrupted the ER membrane and therefore released the pro-
tein. Additional experiments will be necessary to address
this question in more detail.
Recently, Ostrerova et al. (1999) showed that a-synuclein
is homologous to the group of 14–3-3 proteins and that it
binds to 14–3-3 as well as to several 14–3-3 interacting
proteins such as protein kinase C and BAD. Evidence also
has been presented that both a-synuclein and 14–3-3 pro-
teins function as chaperones (Souza et al., 2000); however,
the involvement of these proteins in signaling pathways as
well as their participation in the pathogenesis of neurode-
generative disorders such as Parkinson’s, Alzheimer’s, and
Huntington’s disease has also been described (Layfield et al.,
1996; Polymeropoulos et al., 1997; Charles et al., 2000;). For
example, a-synuclein immunoreactivity has been detected
in inclusion bodies with aggregated, ubiquitinated hunting-
tin protein of HD patients and transgenic mice, suggesting
that the redistribution of this protein to inclusions might
influence disease progression (Charles et al., 2000). Our re-
sults strongly support the importance of these findings.
Wild-type and mutated a-synuclein have also been identi-
fied in Lewy bodies of Parkinson’s disease patients. Further-
more, genetic studies have identified point mutations in the
a-synuclein protein that cause familial Parkinson’s disease
and enhance the aggregation of this protein (Polymeropou-
los et al., 1997; Conway et al., 1998). With regard to 14–3-3,
association of this class of proteins with neurofibrillary tan-
Figure 6. Colocalization of en-
dogenous 14–3-3, TIA-1, and
a-synuclein with HD exon 1 aggre-
gates. Expression of HDQ83 was
induced for 3 d by removal of
doxycycline from the culture me-
dium. Cells were double immuno-
labeled with antibodies recogniz-
ing 14–3-3/HDQ83 (a–c), TIA-1/
HDQ83 (d–f), and a-synuclein/
HDQ83 (g–i). HDQ83 aggregates
were immunolabeled with anti-
Flag antibody coupled to FITC-
conjugated antibody (a–c, g–i;
green) or CAG53b antibody cou-
pled to FITC-conjugated antibody
(d–f). The proteins 14–3-3, TIA-1,
and a-synuclein were detected
with antibodies coupled to a CY3-
conjugated antibody (red). Nuclei
were stained with Hoechst. Bar, 5
mm.
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gles in Alzheimer’s disease brains has been reported (Lay-
field et al., 1996). Neurofibrillary tangles are formed from the
hyperphosphorylated microtubule-associated tau protein,
and there is evidence that the mitogen-activated protein
kinase pathway is responsible, at least in part, for the phos-
phorylation of tau (Drewes et al., 1992). 14–3-3 proteins are
Figure 7. Electron micrographs of 293 Tet-Off cells containing HDQ83 aggregates. After HDQ83 expression for 3–5 d, cells were fixed as
described in MATERIALS AND METHODS and viewed by electron microscopy. (a–c) Different magnifications of a cell containing a typical
perinuclear inclusion body. At higher magnifications, HDQ83 fibrils with a diameter of ;10 nm can be observed. Immunogold labeling of
cells with the HD1 antibody confirmed the identity of the HDQ83 fibrils (d). Immunogold labeling of cells also reveals that the proteins
ubiquitin (h) and 14–3-3 (i) are present in the interior of inclusion bodies. In cells with perinuclear inclusion bodies, ultrastructural changes
such as large indentations of the nuclear envelope (e), disruption of the nuclear membrane (f), and concentration of mitochondria in the
vicinity of inclusion bodies (g) are observed. In f, alterations of the nuclear envelope are indicated by arrows.
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highly abundant in brain, and they have been shown to play
a central role in the mitogen-activated protein kinase signal-
ing cascade (Xing et al., 2000). Binding of 14–3-3 proteins to
target proteins is dependent on their phosphorylation of
Ser/Thr residues (Aitken, 1996). Recently, Tzivion et al.
(2000) showed that 14–3-3 proteins interact with phosphor-
ylated vimentin. Moreover, an association of these proteins
with the centrosome has been described (Pietromonaco et al.,
1996). These results suggest that 14–3-3 proteins link intra-
cellular signaling cascades to the protein degradation ma-
chinery at the centrosome; however, further studies will be
required to assess the biochemical and biophysical proper-
ties of this class of proteins. Furthermore, it will be interest-
ing to see whether 14–3-3 proteins are also present in cyto-
plasmic or nuclear inclusion bodies, or both, of HD patients.
Our data demonstrate that the protein TIA-1 is another
constituent of the perinuclear inclusion bodies. TIA-1 is a
poly(A)1 RNA binding protein that continuously shuttles
between the nucleus and the cytoplasm, suggesting that it
participates in the nucleocytoplasmic transport of selected
mRNAs. Recently, evidence has been presented that TIA-1
and its related homologue TIAR regulate the general trans-
lational arrest that accompanies environmental stress (Ked-
ersha et al., 1999). After a stress stimulus, these proteins
recruit most cytoplasmic mRNAs to discrete cytoplasmic
foci known as stress granules. Concentration of mRNAs in
these granules prevents their translational initiation. Thus,
Figure 9. Proposed mechanism for the formation of perinuclear inclusion bodies. Top, misfolded proteins, including N-terminal huntingtin
fragments with 20 glutamines (HDQ20; blue) are ubiquitinated (small red circles) and degraded in a hypothetical organelle, the degrasome,
containing the proteasomal subcomplexes 11S, 19S, and 20S and the heat shock proteins Hsp40 and Hsp70. Bottom, huntingtin fragments
with 51 glutamines (HDQ51; blue) form insoluble aggregates that resist proteolysis and accumulate in the degrasome. As a response,
additional proteins like the potential chaperones BiP and 14–3-3, a-synuclein, Ab, and presumably many others are recruited and coated with
vimentin, forming the aggresome.
Figure 8. Expression of mutant HD exon 1 protein is toxic for 293
Tet-Off cells. Expression of HD exon 1 proteins with 20, 51, and 83
glutamines was induced for 4 d, and cell viability was determined
using the XTT assay as described in MATERIALS AND METHODS.
Values shown are the average of nine determinations 6 SE.
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TIA-1 and TIAR might function as translational silencers
that influence the duration of a stress-induced translational
arrest. Very recently, experimental evidence in support of
this hypothesis was presented. Piecyk et al. (2000) showed
that TIA-1 represses the expression of tumor necrosis factor
alpha in mouse cells. The reason for the accumulation of
TIA-1 in HD exon 1 protein aggregates is presently un-
known; however, in light of these observations, it will be
interesting to examine whether in addition to TIA-1, mRNAs
are also concentrated in the perinuclar inclusions. A stress-
induced accumulation of mRNAs could significantly alter
the expression of proteins in mammalian cells. In this regard
it is interesting to note that polyQ repeat length–dependent
changes in the expression levels of neurotransmitter recep-
tors and proteins involved in calcium signaling have re-
cently been described (Luthi-Carter et al., 2000).
During the last years, several independent in vivo and in
vitro studies have presented evidence that the formation of
intracellular inclusion bodies with aggregated polyQ-con-
taining proteins is nontoxic or even beneficial for mamma-
lian cells (Klement et al., 1998; Saudou et al., 1998). Our
present studies do not support these results. On the con-
trary, we find that the process of inclusion body formation
correlates with toxicity in 293 Tet-Off cells. Viability of cells
expressing HD exon 1 protein with 83 and 51 glutamines
was reduced by ;60 and 40%, respectively, compared with
cells expressing an HD exon 1 protein with 20 glutamines
(Figure 8). The molecular mechanism by which the process
of aggregate formation causes toxicity to cells is unclear;
however, our data suggest that formation of insoluble fibril-
lar structures interferes with proteasomal activity. It is pos-
sible that the 19S and 11S regulatory subcomplexes of the
26S proteasome recognize and bind the misfolded HD exon
1 protein; however, because of aggregate formation, the
ubiquitinated polyQ-containing proteins cannot be de-
graded efficiently, and therefore the release of free ubiquitin
molecules from the huntingtin fibrils by the cellular deubiq-
uitinating enzymes is blocked. This could lead to the deple-
tion of free ubiquitin in the cell, particularly when the
amount of insoluble HD exon 1 protein increases. Because it
has been shown that the primary function of the proteasome
is the rapid degradation of proteins with abnormal folding
(Voges et al., 1999), the formation of HD exon 1 protein
aggregates could lead indirectly to the accumulation of reg-
ulatory proteins such as transcription factors, oncogene
products, tumor suppressors, and rate-limiting enzymes
that might be highly toxic for mammalian cells.
Our findings have several implications for the develop-
ment of a treatment against HD and the related glutamine
disorders (Heiser et al., 2000). We propose that either inhi-
bition of huntingtin aggregation or stimulation of the natu-
ral clearance of accumulated disease protein by small mol-
ecules is an effective therapeutic strategy against these
neurodegenerative diseases. Also, reducing the cellular con-
centration of the mutant huntingtin protein by antisense
oligonucleotides or ribozymes could significantly slow
down disease progression. Previously, we have shown that
overexpression of the heat shock proteins Hsp70 and Hsp40
inhibits the formation of HD exon 1 aggregates in both yeast
and mammalian cells (Muchowski et al., 2000; E. Wanker,
unpublished results), and similar results were obtained
when transiently transfected COS cells expressing a mutated
HD exon 1 protein were treated with certain chemical com-
pounds (Heiser et al., 2000). Together, these findings suggest
that the inhibition of aggregate formation and the stimula-
tion of the heat shock response by small molecules might be
a feasible strategy toward a therapy for HD and related
disorders. To our knowledge, chemical compounds that spe-
cifically stimulate the proteolytic digestion of a mutant dis-
ease protein have not yet been described. Therefore, a future
challenge will be to identify chemical compounds that se-
lectively activate the ubiquitin–ATP-dependent pathway
and thereby inhibit the accumulation of aggregation-prone
huntingtin protein in mammalian cells.
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